Prespecified secondary analysis of ABYSS (3,698 post-MI patients, EF ≥40%): baseline heart rate was not associated with the primary endpoint (22.4% vs 21.8% vs 21.6%), but the top tertile had more death, MI or stroke (adjusted HR 1.55); interrupting β-blockers raised HR.
Secondary analysisn = 3,698 patients
Zeitouni et al. Heart Rate and Cardiovascular Outcomes in Post-Myocardial Infarction Patients Treated by β-Blockers: A Secondary Analysis of the ABYSS Trial